MYOS Corporation Studies Muscle and Strength Building Activity of Fortetropin in Resistance Trained Male Subjects
April 09, 2014 07:35 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Apr 9, 2014) - MYOS Corporation ("MYOS" or the "Company") (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
MYOS Corporation Reports 2013 Fourth Quarter and Full Year Results
April 01, 2014 07:35 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Apr 1, 2014) - MYOS Corporation (OTCBB: MYOS)
Company Demonstrates Solid Market Expansion and Growth with 276% Increase in Gross...
MYOS Corporation Joins Scientific Working Group Aging in Motion to Develop Patient Centered Treatment Measures for Sarcopenia
March 27, 2014 07:35 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Mar 27, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
MYOS Corporation Takes Steps to Make a Difference in the Fight Against Muscle Disease at the New Jersey MDA Muscle Walk
March 17, 2014 08:05 ET
|
MYOS Corporation
CEDAR KNOLLS, NJ--(Marketwired - Mar 17, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
MYOS Corporation to Present Abstract on Lipidomic and Proteomic Studies of MYO-T12(R) at the International Conference on Frailty and Sarcopenia Research
March 12, 2014 08:05 ET
|
MYOS Corp
CEDAR KNOLLS, NJ--(Marketwired - Mar 12, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
MYOS Corporation Initiates Clinical Study of MYO-T12(R) in Adult Women
February 27, 2014 08:05 ET
|
MYOS Corp
CEDAR KNOLLS, NJ--(Marketwired - Feb 27, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
MYOS Corporation Appoints Christopher Pechock to Its Board of Directors
February 24, 2014 08:05 ET
|
MYOS Corp
CEDAR KNOLLS, NJ--(Marketwired - Feb 24, 2014) - MYOS Corporation (OTCBB: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
February 13, 2014 07:35 ET
|
MYOS Corp
CEDAR KNOLLS, NJ--(Marketwired - Feb 13, 2014) - MYOS Corporation (OTCBB: MYOSD), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
MYOS Board of Directors Issues Letter to Shareholders
February 10, 2014 07:35 ET
|
MYOS Corp
CEDAR KNOLLS, NJ--(Marketwired - Feb 10, 2014) - MYOS Corporation (OTCBB: MYOSD), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...
MYOS Corporation Announces 1-for-50 Reverse Stock Split Following Five Consecutive Quarters of Market Expansion and Revenue Growth
February 10, 2014 07:30 ET
|
MYOS Corp
CEDAR KNOLLS, NJ--(Marketwired - Feb 10, 2014) - MYOS Corporation (OTCBB: MYOSD), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of...